|
KMID : 0931320120120010023
|
|
대한상부위장관.헬리코박터학회지
2012 Volume.12 No. 1 p.23 ~ p.26
|
|
|
The Efficacy of Short-term Administration of Revaprazan on Gastroesophageal Reflux Symptoms: Comparison with Half Dose Esomeprazole, a Pilot Study
|
|
Lee Hae-Mi
Kim Byung-Wook
Kim Joon-Sung
Im Eun-Joo
Kim Jong-In
Kang Bong-Koo
Ji Jeong-Seon
Lee Bo-In
Choi Hwang
|
|
|
Abstract
|
|
|
Background/Aims: Revaprazan, an acid pump antagonist, is a kind of gastric acid suppressant and is prescribed for the treatment of peptic ulcers and gastritis. However, the efficacy of revaprazan on gastroesophageal reflux symptoms has not been established. The aim of this study was to evaluate the short-term efficacy of revaprazan on gastroesophageal reflux symptoms.
Materials and Methods: Patients who complained of gastroesophageal reflux symptoms without any specific diseases except gastritis on esophagogastroduodenoscopy were included in this study. Patients were randomized to receive revaprazan 200 mg or esomeprazole 20 mg for 2 weeks. Symptoms were assessed by using the frequency score questionnaire before and after treatment.
Results: Fifteen patients received revaprazan and 19 patients received esomeprazole. The changes of the symptom frequency score before and after treatment were 7.0 in revaprazan group and 8.6 in esomeprazole group (P=0.778).
Conclusions: Revaprazan is not inferior to esomeprazole in therapeutic efficacy for gastroesophageal reflux symptoms and is a safe and useful therapeutic agent to reduce the frequency of gastroesophageal reflux symptoms.
|
|
|
KEYWORD
|
|
|
Revaprazan, Esomeprazole, Gastroesophageal reflux
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|